Literature DB >> 19779035

The role of let-7 in cell differentiation and cancer.

Benjamin Boyerinas1, Sun-Mi Park, Annika Hau, Andrea E Murmann, Marcus E Peter.   

Abstract

MicroRNAs (miRNAs or miRs) are small noncoding RNAs capable of regulating gene expression at the translational level. Current evidence suggests that a significant portion of the human genome is regulated by microRNAs, and many reports have demonstrated that microRNA expression is deregulated in human cancer. The let-7 family of microRNAs, first discovered in Caenorhabditis elegans, is functionally conserved from worms to humans. The human let-7 family contains 13 members located on nine different chromosomes, and many human cancers have deregulated let-7 expression. A growing body of evidence suggests that restoration of let-7 expression may be a useful therapeutic option in cancers, where its expression has been lost. In this review, we discuss the role of let-7 in normal development and differentiation, and provide an overview of the relationship between deregulated let-7 expression and tumorigenesis. The regulation of let-7 expression, cancer-relevant let-7 targets, and the relationship between let-7 and drug sensitivity are highlighted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19779035     DOI: 10.1677/ERC-09-0184

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  294 in total

1.  The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche.

Authors:  Hila Toledano; Cecilia D'Alterio; Benjamin Czech; Erel Levine; D Leanne Jones
Journal:  Nature       Date:  2012-05-23       Impact factor: 49.962

2.  MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.

Authors:  Maroof Alam; Rehan Ahmad; Hasan Rajabi; Donald Kufe
Journal:  Mol Cancer Res       Date:  2014-11-03       Impact factor: 5.852

3.  microRNA-dependent temporal gene expression in the ureteric bud epithelium during mammalian kidney development.

Authors:  Vidya K Nagalakshmi; Volkhard Lindner; Andy Wessels; Jing Yu
Journal:  Dev Dyn       Date:  2014-11-23       Impact factor: 3.780

4.  Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs.

Authors:  Robert J A Frost; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

5.  Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells.

Authors:  Xinping Fu; Armando Rivera; Lihua Tao; Bart De Geest; Xiaoliu Zhang
Journal:  Mol Ther       Date:  2011-12-06       Impact factor: 11.454

Review 6.  Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.

Authors:  Liqin Du; Alexander Pertsemlidis
Journal:  J Mol Cell Biol       Date:  2011-01-28       Impact factor: 6.216

7.  Two miRNA clusters, Mir-17-92 (Mirc1) and Mir-106b-25 (Mirc3), are involved in the regulation of spermatogonial differentiation in mice.

Authors:  Ming-Han Tong; Debra Ann Mitchell; Samantha Dawn McGowan; Ryan Evanoff; Michael D Griswold
Journal:  Biol Reprod       Date:  2012-03-19       Impact factor: 4.285

8.  Proinflammatory role of let-7 miRNAs in experimental asthma?

Authors:  Manish Kumar; Ulaganathan Mabalirajan; Anurag Agrawal; Balaram Ghosh
Journal:  J Biol Chem       Date:  2010-11-26       Impact factor: 5.157

9.  Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Jiyoung Kim; Xiaoling Yang; Jennifer L Martindale; Kumiko Tominaga-Yamanaka; Elizabeth J White; Arturo V Orjalo; John L Rinn; Stefan G Kreft; Gerald M Wilson; Myriam Gorospe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.

Authors:  Shin-ichiro Ohno; Masakatsu Takanashi; Katsuko Sudo; Shinobu Ueda; Akio Ishikawa; Nagahisa Matsuyama; Koji Fujita; Takayuki Mizutani; Tadaaki Ohgi; Takahiro Ochiya; Noriko Gotoh; Masahiko Kuroda
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.